Search results for abx831301

Bimekizumab, Abbexa, abx831301

Bimekizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IL17A, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Bimekizumab has been used in trials studying the treatment of Psoriatic arthritis, Ankylosing Spondylitis, Chronic Plaque Psoriasis, and Mild to Moderate Psoriasis.